CD274 and acute myeloid leukemia: Herbrich et al. [74] evaluated bone marrow and peripheral blood samples by single-cell mass cytometry (CYTOF) profiling of serially collected samples from nine R/R AML patients treated with azacitidine and PD-L1 inhibitor avelumab (NCT02953561).